Scientific Poster Presentation II

Sunday, April 26, 2009: 8:00 AM-9:30 AM
Session Organizer:
Emma Webb, ACCP
Papers:
1
Use of oral and intravenous N-acetylcysteine for prevention of contrast-induced nephropathy in a Singapore hospital
Candice Yong, BScPharm(Hons), Department of Pharmacy, Changi General Hospital; Ian Wee, MPharm(Clin Pharm), Department of Pharmacy, Changi General Hospital; Michelle See, BScPharm(Hons), Department of Pharmacy, Changi General Hospital
2
Financial impact of venous thromboembolism prophylaxis strategy on costs associated with heparin induced thrombocytopenia: A Monte Carlo simulation
Eli N. Deal, Pharm.D., Barnes Jewish Hospital; James M. Hollands, Pharm.D., Barnes Jewish Hospital; Angela R. Wills, Pharm.D., Barnes Jewish Hospital; Lee P. Skrupky, Pharm.D., Barnes Jewish Hospital; Scott T. Micek, Pharm.D., Barnes Jewish Hospital
3
Cardiometabolic risk factor knowledge of participants in a worksite health screening
Amy M. Franks, Pharm.D., University of Arkansas for Medical Sciences College of Pharmacy; T. Scott Warmack, Pharm.D., University of Arkansas for Medical Sciences College of Pharmacy; Donna S. West, Ph.D., University of Arkansas for Medical Sciences College of Pharmacy
4
Comparison of safety outcomes in three models of anticoagulation management
Kelly M. Rudd, Pharm.D., BCPS, Bassett Healthcare
5
Warfarin therapy in atrial fibrillation: a comparison between established and new patients
Julie M. Sease, Pharm, D, South Carolina College of Pharmacy; S. Scott Sutton, Pharm D, South Carolina College of Pharmacy
6
Evaluation of guideline adherence for the treatment of asthma in family medicine clinics
Sandra L. Kim, PharmD, University of Illinois at Chicago; Mitzi Wasik, PharmD, BCPS, University of Illinois at Chicago; Marlowe Djuric, PharmD, University of Illinois at Chicago; Kristen L. Goliak, PharmD, University of Illinois at Chicago; Seema Patel, PharmD, University of Illinois at Chicago; Lori A. Wilken, PharmD, CDE, AE-C, University of Illinois at Chicago; Leslie A. Briars, PharmD, University of Illinois at Chicago; Louise Parent-Stevens, PharmD, BCPS, University of Illinois at Chicago
7
Evaluation of antihypertensive medication adherence and intensity of treatment in the Improving Blood Pressure in Colorado Hypertension study
Lesley K. Welch, PharmD, Denver VA Medical Center; Kari L. Olson, PharmD, Kaiser Permanente Colorado Region; Karen Snow, PharmD, Denver Health Medical Center; Mary E. Plomondon, PhD, Denver VA Medical Center; Anne Lambert-Kerzner, MSPH, Denver Health Medical Center; David W. Brand, MSPH, Kaiser Permanente Colorado Region; Edward P. Havranek, MD, Denver Health Medical Center; David J. Magid, MD, MPH, Kaiser Permanente Colorado Region; P. Michael Ho, MD, PhD, Denver VA Medical Center
10E
Combination of Angiotensin-receptor blocker, Calcium-channel blocker and Diuretic is Safe and Effective in the Management of Severe Hypertension in Blacks
John Flack, MD, MPh, Wayne State University School of Medicine; David Calhoun, MD, University of Alabama at Birmingham; Lisa Satlin, MS, RD, Novartis Pharmaceuticals Corporation; Michaela Barbier, PhD, Novartis Pharma AG; Patrick Brunel, MD, Novartis Pharma AG; Robert Hilkert, MD, FACC, Novartis Pharmaceuticals Corporation
12
Over-the-counter medicines and the patient: distribution and services in Flemish community pharmacy
Steven RA Simoens, MSc, PhD, Katholieke Universiteit Leuven; Marieke Lobeau, PharmD, Royal Pharmaceutical Society of East-Flanders; Koen Verbeke, PharmD, PhD, Pharmaceutical Society of Bruges and Ostend; Arthur van Aerschot, PharmD, PhD, Katholieke Universiteit Leuven
13
Prevalence of Drug-Related Problems in Self-medication (OTC Use)
Nina Griese, Ph.D., Center for Drug Information and Pharmacy Practice (ZAPP), ABDA - Federal Union of German Associations of Pharmacists; Karin Berger, RPh, MPH, Center for Drug Information and Pharmacy Practice (ZAPP), ABDA - Federal Union of German Associations of Pharmacists; Christiane Eickhoff, Ph.D., Center for Drug Information and Pharmacy Practice (ZAPP), ABDA - Federal Union of German Associations of Pharmacists; Ralf Goebel, Ph.D., Center for Drug Information and Pharmacy Practice (ZAPP), ABDA - Federal Union of German Associations of Pharmacists; Andrea Haemmerlein, Ph.D., Center for Drug Information and Pharmacy Practice (ZAPP), ABDA - Federal Union of German Associations of Pharmacists; Uta Mueller, Ph.D., MPH, Center for Drug Information and Pharmacy Practice (ZAPP), ABDA - Federal Union of German Associations of Pharmacists; Christiane Sauerwein, RA., Center for Drug Information and Pharmacy Practice (ZAPP), ABDA - Federal Union of German Associations of Pharmacists; Susanne vom Scheidt, RA., Center for Drug Information and Pharmacy Practice (ZAPP), ABDA - Federal Union of German Associations of Pharmacists; Margit Schmidt, RA., Center for Drug Information and Pharmacy Practice (ZAPP), ABDA - Federal Union of German Associations of Pharmacists; Martin Schulz, Ph.D., Center for Drug Information and Pharmacy Practice (ZAPP), ABDA - Federal Union of German Associations of Pharmacists
14E
The culture of safety: results of a cross-sectional survey of 998 community pharmacists
Darren M. Ashcroft, PhD, School of Pharmacy and Pharmaceutical Sciences, University of Manchester; Dianne Parker, PhD, School of Pharmacy and Pharmaceutical Sciences, University of Manchester
15
Impact of access to clinical information on community pharmacists' interventions with polymedicated patients: a randomized controlled trial
Natacha Beaulieu, B.Pharm., M.Sc., Pharmacie Jean-François Guévin; Catherine Cellini, B.Pharm., M.Sc., Pharmacie Marc Champagne; Amélie Garneau, B.Pharm., M.Sc., CSSS de Laval - Cité de la Santé; Lyne Lalonde, B.Pharm., PhD, CSSS de Laval - Cité de la Santé et Faculté de pharmacie, Université de Montréal; Olivier Turpin-Lavallée, B.Pharm., M.Sc., CSSS de Laval - Cité de la Santé; Hélène Lachance-Demers, B.Pharm, M.Sc, CSSS de Laval - Cité de la Santé; Alain Turcotte, MD, CSSS de Laval - Cité de la Santé; Marie-Claude Vanier, B.Pharm., M.Sc, CSSS de Laval - Cité de la Santé et Faculté de pharmacie, Université de Montréal
16
Embarrassment and purchasing of contraceptives: a study of access and provision of information in pharmacies
Daniel Ashwood, BA, University of Iowa; Karen Farris, PhD, University of Iowa; Anne Bonsall Hoekstra, MA, University of Northern Iowa; Mary Losch, PhD, University of Northern Iowa
19
Effect of topical insulin on cutaneous wound healing in non-diabetic and acute diabetic rats
Sule Apikoglu-Rabus, Ph.D., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Fikret V. Izzettin, Prof., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Pinar Turan, Ph.D., Marmara University Faculty of Medicine, Histology-Embryology Department; Feriha Ercan, Prof., Marmara University Faculty of Medicine, Histology-Embryology Department
20
Extent of Information Desired in patients with major depression: what happens after hospital discharge?
Franciska A. Desplenter, PharmD, Katholieke Universiteit Leuven; Gert Laekeman, Prof., PhD, PharmD, Katholieke Universiteit Leuven; Koen Demyttenaere, Prof. MD., Katholieke Universiteit Leuven; Vza Psychiatry, PharmD, Flemish Association of Hospital Pharmacists - Psychiatry; Steven Simoens, Prof. MSc., Katholieke Universiteit Leuven
21
Effects of topical verapamil administration on acute tympanic membrane perforation in guinea pigs
Mert Eken, M.Sc, Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Fikret Vehbi Izzettin, Prof, Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Mehmet Eken, Ph.D, 2nd ENT, Kartal Training and Research Hospital; Mesut Sancar, Ph.D, Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Betül Okuyan, MSc, Marmara University Faculty of Pharmacy, Clinical Pharmacy Department
22
Impact of a continuous professional development program on the counseling practices and attitudes of the pharmacists about emergency contraceptive pills
Sule Apikoglu-Rabus, Ph.D., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Fikret V. Izzettin, Prof., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department
23E
Safer pharmacy practice: a preliminary study of significant event analysis and peer feedback
Nicholas Bradley, Ph.D, Postgraduate Medicine, NHS Education for Scotland; Ailsa Power, MRPharmS Ph.D, Pharmacy Directorate, NHS Education for Scotland; Hannah Hesselgreaves, Ph.D, Pharmacy Directorate, NHS Education for Scotland; Fiona McMillan, MRPharmS, Pharmacy Directorate, NHS Education for Scotland; Paul Bowie, Ph.D, Pharmacy Directorate, NHS Education for Scotland; Rose Marie Parr, MRPharmS, Ph.D, Pharmacy Directorate, NHS Education for Scotland
24
Educational Interventions to Curb the Inappropriate Use of Acid-Suppressive Agents on a University Hospital Internal Medicine Service
Amanda D. Osta, MD, The University of Michigan Health System; Vikas I. Parekh, MD, The University of Michigan Health System; Randolph E. Regal, Pharm.D., The University of Michigan Health System and College of Pharmacy
25
Impact of an Evidence Based Medicine elective course on student performance on Advanced Pharmacy Practice Experiences
Aida R. Bickley, PharmD, Candidate, University of South Carolina College of Pharmacy; Catherine E. McAbee, PharmD, Candidate, South Carolina College of Pharmacy-USC Campus; P. Brandon Bookstaver, PharmD, South Carolina College of Pharmacy-USC Campus
27
Interdisciplinary student team training in geriatrics
Anne L. Hume, PharmD, University of Rhode Island; Alicia Curtin, PhD, GNP, Memorial Hospital of Rhode Island; Philip G. Clark, ScD, University of Rhode Island
28
Geriatric pharmacotherapy: an approach to active self-directed learning
Erica Estus, PharmD, CGP, University of Rhode Island; Anne Hume, PharmD, FCCP, BCPS, University of Rhode Island; Norma Owens, PharmD, FCCP, BCPS, University of Rhode Island
29
Patient education and health promotion: a bridge between disease and illness
Daniela Scala, Pharmacist, Centre of Biotechnologies, Cardarelli Hospital; Maria D'Avino, Physician, Centre for the diagnosis and therapy of arterial hypertension; Santolo Cozzolino, Pharmacist, Centre of Biotechnologies, Cardarelli Hospital; Antonio Mancini, Pharmacist, Centre of Biotechnologies, Cardarelli Hospital; Barbara Andria, Pharmacist, Centre of Biotechnologies, Cardarelli Hospital; Giuseppe Caruso, Physician, Centre for the diagnosis and therapy of arterial hypertension; Domenico Caruso, Physician, Centre for the diagnosis and therapy of arterial hypertension
30
The development of a therapeutic patient education project: the journey from the idea to the realization
Daniela Scala, Pharmacist, Centre of Biotechnologies, Cardarelli Hospital; Maria D'Avino, Physician, Caentre for the Diagnosis and Therapy of Arterial Hypertension; Santolo Cozzolino, Pharmacist, Centre of Biotechnologies, Cardarelli Hospital; Antonio Mancini, Pharmacist, Centre of Biotechnologies, Cardarelli Hospital; Barbara Andria, Pharmacist, Centre of Biotechnologies, Cardarelli Hospital; Giuseppe Caruso, Physician, Caentre for the Diagnosis and Therapy of Arterial Hypertension; Domenico Caruso, Physician, Caentre for the Diagnosis and Therapy of Arterial Hypertension
31
Comparison of student performance on multiple choice questions divided into three cognitive domains using Bloom's Taxonomy
Zachary A. Stacy, Pharm.D., BCPS, St. Louis College of Pharmacy; Amy M. Tiemeier, Pharm.D., St. Louis College of Pharmacy; John M. Burke, Pharm.D., St. Louis College of Pharmacy
32
The impact of pharmacy education on the use of weight-based fosphenytoin dosing in the emergency department
April D. Miller, PharmD, South Carolina College of Pharmacy-USC Campus; Carrie S. Wylie, PharmD, Palmetto Health Richland; Joseph Kohn, PharmD, Palmetto Health Richland
33
Factors associated with adverse drug events in a french emergency department
Lucien Roulet, Fellow, UPRES EA 38 26, Faculté de Médecine; Jean-Benoit Hardouin, PhD, EA 4572 "Biostatistics, Clinical Research and Sujective Measures in Health Sciences" - Faculté de Pharmacie; Florence Ollivier, PharmD, CHU, MEDQUAL; Gilles Potel, M.D., Ph.D., CHU, Emergency department; Françoise Ballereau, PharmD., Ph.D., CHU, MEDQUAL; Nathalie Asseray, M.D., Ph.D., UPRES EA 38 26, Faculté de Médecine
34E
Exenatide utilization and effectiveness in a health plan population
Rolin Wade, RPh, MS, HealthCore, Inc.; Brock Schroeder, PhD, Amylin Pharmaceuticals, Inc.; Ralph Quimbo, MA, HealthCore, Inc.; Derek Misurski, PhD, Eli Lilly and Company; Rosalind Fabunmi, PhD, Amylin Pharmaceuticals, Inc.; Loretta Nielsen, PhD, Amylin Pharmaceuticals, Inc.; Matthew Wintle, MD, Amylin Pharmaceuticals, Inc.
35
Occurrence of Hemoglobin A1c testing during inpatient hospitalization at Wellspan
Molly A. Walbrown, Pharm.D., CACP, CDE, Wellspan Health/York Hospital
36
Evaluation of prescribing patterns of sitagliptin based on estimated glomelular filtration rates in two multi specialty practices
M. Shawn McFarland, PharmD, Alvin C. York Veterans Administration; Jeffery Tunney, PharmD, Alvin C. York Veterans Administration; Chad Gentry, PharmD, University of Tennessee / Holston Medical Group; Benjamin N. Gross, Pharm., D., University of Tennessee; L. Brian Cross, PharmD, University of Tennessee / Holston Medical Group
37
Assessment of quality of diabetes care for type 2 diabetics
Sule Apikoglu-Rabus, Ph.D., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Mehmet Hursitoglu, Assist., Prof., Vakif Gureba Teaching and Research Hospital, Internal Medicine Department; Sami S. Bulgurlu, Ph.D., Haydarpasa Numune Teaching and Research Hospital, Internal Medicine Department; Akin Dayan, Ph.D., Haydarpasa Numune Teaching and Research Hospital, Internal Medicine Department; Nilcihan Yolcu, Ph.D., Haydarpasa Numune Teaching and Research Hospital, Internal Medicine Department; Nuray Gebologlu, RN, Haydarpasa Numune Teaching and Research Hospital, Internal Medicine Department; Fikret V. Izzettin, Prof., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department
38
Identifying comorbid depression among adults with diabetes in secondary databases
Marianne McCollum, PhD, University of Colorado Denver School of Pharmacy; Julia F. Slejko, BS, University of Colorado Denver School of Pharmacy; William V. Padula, MS, University of Colorado Denver School of Pharmacy
39E
A comparative study of the level of agreement with statements on pharmaceutical ethics between interns in France and Quebec
Jean-François Bussières, B.Pharm, M.Sc., CHU Sainte-Justine; Karin Scharr, DPharm, CHU Sainte-Justine; Sonia Prot-Labarthe, DPharm, CHU Sainte-Justine; Denis Lebel, B. Pharm, M.Sc., CHU Sainte-Justine; Olivier Bourdon, DPharm, APHP hôpital Robert Debré
40
Survey of physician knowledge regarding acetaminophen dosing, toxicity, and product recognition
Lori B. Hornsby, PharmD, Auburn University Harrison School of Pharmacy; Miranda Andrus, PharmD, Auburn University Harrison School of Pharmacy; Jessica Starr, PharmD, Auburn University Harrison School of Pharmacy
41
The Role of Lactobacillus in the Prevention of Antibiotic-Associated Diarrhea
Pramodini B. Kale-Pradhan, Pharm.D., Wayne State University; Sheila M. Wilhelm, PharmD, BCPS, Wayne State University; Harjot Jassal, Pharm.D. Candidate, Wayne State University; Raymond Cha, Pharm.D., Wayne State University
42
The effect of arginine and omega 3 fatty acids in critically ill and surgical patients
Sheila M. Wilhelm, PharmD, BCPS, Wayne State University; Mark Essak, Pharm.D., Candidate, Wayne State University; Pramodini B. Kale-Pradhan, Pharm.D., Wayne State University; Raymond Cha, Pharm.D., Wayne State University
45E
Helping patients use their medicines more effectively: A pilot study of medicine use reviews in the UK
James A. Desborough, MPharm, PhD, University of East Anglia; David J. Wright, BPharm, PhD, University of East Anglia; John Wood, BSc, MSc, BSc, University of East Anglia; Richard C Holland, BA, BM Bch, PhD, University of East Anglia
46
Identification of resources to provide appropriate language services for Limited English Proficient patients
Priti N. Patel, PharmD, BCPS, St. John's University; Emily M. Ambizas, PharmD, St. John's University
47E
Pre- vs. Post-National Coverage Determination (NCD) blood utilization and hemoglobin values among Medicare patients treated with erythropoietic-stimulating agents (ESAs) for chemotherapy-induced anemia (CIA)
Tanya Burton, PhD, Abt Bio-Pharma Solutions, Inc.; Kay Larholt, ScD, Abt Bio-Pharma Solutions, Inc.; Elizabeth Apgar, MPH, Abt Bio-Pharma Solutions, Inc.; Chris Pashos, PhD, Abt Bio-Pharma Solutions, Inc.; Brahim Bookhart, MBA, MPH, Centocor Ortho Biotech Services, LLC; Mitra Corral, MS, MPH, Centocor Ortho Biotech Services, LLC; Catherine T. Piech, MBA, Centocor Ortho Biotech Services, LLC; R. Scott McKenzie, MD, Centocor Ortho Biotech Services, LLC
48
Interest in and knowledgebase of practice based research networks (PBRNs): a survey of Maryland pharmacists
Heather B. Congdon, PharmD, CACP, CDE, University of Maryland School of Pharmacy; Melissa Kim, PharmD Candidate, University of Maryland School of Pharmacy
49
Montenegro primary care physicians awareness of evidence based medicine – call for a clinical pharmacist intervention?
Ivana Ilickovic, MSc, Pharmaswiss; Branislava Miljkovic, PhD, School pf pharmacy, University of Belgrade; Sandra Vezmar, PhD, School pf pharmacy, University of Belgrade
50E
Hypoglycemia and costs in patients newly initiated on exenatide or insulin glargine
Rolin Wade, RPh, MS, HealthCore, Inc.; Loretta Nielsen, PhD, Amylin Pharmaceuticals, Inc.; Rosalind Fabunmi, PhD, Amylin Pharmaceuticals, Inc.; Ralph Quimbo, MA, HealthCore, Inc.; Brock Schroeder, PhD, Amylin Pharmaceuticals, Inc.; Marjan Massoudi, PharmD, Amylin Pharmaceuticals, Inc.; Derek Misurski, PhD, Eli Lilly and Company; Matthew Wintle, MD, Amylin Pharmaceuticals, Inc.
57
Effects of Nigella Sativa oil on cutaneous wound healing in rats
Fikret V. Izzettin, Prof., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Yasemin Varol, MSc., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Sule Apikoglu-Rabus, Ph.D., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Adile Cevikbas, Prof., Marmara University Faculty of Pharmacy, Pharmaceutical Microbiology Department
58
Assessment of HIV-infected patients: a response to the American Heart Association initiative to reduce cardiovascular risk
Kelly Hester, Pharm.D., BCPS, Auburn University Harrison School of Pharmacy; Cara L. Leos, Pharm.D., BCPS, Auburn University Harrison School of Pharmacy
59
Lipid lowering effects of rosuvastatin in HIV-infected patients on Highly Active Antiretroviral Therapy
Humberto R. Jimenez, Pharm.D., BCPS, Saint Michael's Medical Center; Stephen Esker, Pharm.D., Bristol-Myers Squibb Company; Alexander Ganetsky, Pharm.D., Bristol-Myers Squibb Company; Jihad Slim, M.D., Saint Michael's Medical Center
69E
Survey of US colleges/schools of pharmacy concerning international education and research relationships update: past, present and future
Rosalie Sagraves, PharmD, University of Illinois at Chicago; Bruce Currie, PhD, University of California Davis; Joseph Dean, PhD, Samford University
70
Prevalence of diabetes in a managed care organization and healthcare resource utilization in patients with diabetes and hemoglobin A1c above goal
S. Scott Sutton, Pharm.D., South Carolina College of Pharmacy; Julie M. Sease, Pharm, D, South Carolina College of Pharmacy
71
Mortality, lipid monitoring, and therapeutic control of patients coded for myocardial infarction within the past five years and seen at least once in a primary care clinic
Julie M. Sease, Pharm, D, South Carolina College of Pharmacy; S. Scott Sutton, Pharm D, South Carolina College of Pharmacy
73E
EDUCATIONAL needs arising from PATIENT SAFETY INCIDENT REPORTS related to the use of medicines
Rose Marie Parr, PhD, NHS Education for Scotland; Hannah Hesselgreaves, PhD, NHS Education for Scotland; Anne Watson, MSc MEd, NHS Education for Scotland
74E
Identifying, understanding, and overcoming barriers to medication error reporting in hospitals in Nova Scotia, Canada
Nicole R. Hartnell, MSc, Dalhousie University; Neil J MacKinnon, PhD, FCSHP, Dalhousie University; Ingrid Sketris, PharmD, MPA (HSA), Dalhousie University; Steven M. Smith, PhD, St. Mary's University
77
Assessing anticoagulation knowledge in patients new to warfarin therapy
Amanda R. McFee, PharmD, Bassett Healthcare; Kelly M. Rudd, PharmD, BCPS, Bassett Healthcare; Darren M. Triller, PharmD, IPRO
78
Attitudes of hospital pharmacists to reporting medication errors: insights from focus groups
Steven D. Williams, BPharm, School of Pharmacy and Pharmaceutical Sciences, University of Manchester; Darren M. Ashcroft, PhD, School of Pharmacy and Pharmaceutical Sciences, University of Manchester
79E
Examining patient safety climate in the hospital pharmacy setting: a cross sectional survey
Steven D. Williams, BPharm, School of Pharmacy and Pharmaceutical Sciences, University of Manchester; Darren M. Ashcroft, PhD, School of Pharmacy and Pharmaceutical Sciences, University of Manchester
80
MONOCLONAL antibodies in clinical trials: where reconstitute them for a safety use?
Elodie Ostojski, Resident, University hospital; Berenice Des Champs, Pharmacist, University hospital; Christophe Berneron, Pharmacist, University hospital; Beatrice Thielemans, Pharmacist, University hospital
81
Serum zinc concentrations in patients on maintenance hemodialysis and its relationship with anemia, parathyroid hormone concentrations and pruritus severity
Simin Dashti-Khavidaki, Assistant, Professor, Tehran University of Medical Sciences; Hossein Khalili, Associate, Professor, Tehran University of Medical Sciences; Maryam Vahedi, Pharm D, Tehran University of Medical Sciences
82
The evaluation of Gabapentin therapy for pruritus in the Iranian hemodialysis patients
Seyed Mojtaba Sohrevardi, Pharm, D., BCPS, Faculty of pharmacy, yazd medical university; Jalal Azmandian, MD, nephrologist, Faculty of medicine
83E
Effect of Caffeine and Choline on Short-Term Memory
Jamie L. Kearns, Pharm.D., Duquesne University; Vincent J. Giannetti, Ph.D., Duquesne University; David A. Johnson, Ph.D., Duquesne University
84
Evaluating venous thromboembolism (VTE) prophylaxis in neurosurgical patients with craniotomy
Biljana Popovic, Pharm.D., BCPS, BCNSP, Harper University Hospital; Sheila M. Wilhelm, PharmD, BCPS, Wayne State University; Bhattacharya Pratik, MD, Harper University Hospital; Asmita Patel, Pharm.D., Student, Wayne State University; Megha Parikh, Pharm.D., Student, Wayne State University; Lee Anthony, MD, Harper University Hospital; Guthikonda Murali, MD, Harper University Hospital
85
NUCLEIC acid purine based Tamoxifen-Purine analogues as potential anticancer agents
Shashikant Phadtare, Ph.D., College of Pharmacy, Xavier University of Louisiana; Nageswara Kode, Ph.D., College of Pharmacy, Xavier University of Louisiana
86
Opiophobic factors that may contribute to inadequate pain management
Mark H. McKenzie, B.S., Candidate, University of Florida; Michael W. McKenzie, Ph.D., University of Florida College of Pharmacy; Lynda C. McKenzie, M.Ed., University of Florida College of Pharmacy; Carole Kimberlin, Ph.D., University of Florida College of Pharmacy
88
Economic evaluation of a pharmacy led disease and medicine managment programme for patients with COPD
Maher Al-Khdour, BSc., MSc., PhD., Queen's University Belfast and Al-Quds University; Ashley Murray, PhD, Royal Victoria Hospital; Grainne Crealey, PhD, Royal Victoria Hospital; James McElnay, Professor, FCPP, Queen's University Belfast
89
Effectiveness of amlodipine/valsartan single-pill combination therapy in primary care
Joseph E. Biskupiak, PhD, MBA, University of Utah College of Pharmacy; Diana I Brixner, PhD, RPh, University of Utah College of Pharmacy; Drew Griffin Levy, PhD, Novartis Pharmaceutical Corporation; Robert Hilkert, MD, Novartis Pharmaceutical Corporation
91
Costs of cardiovascular disease associated with the use of sunitinib and sorafenib in renal-cell carcinoma
Rex W. Force, PharmD, FCCP, BCPS, Departments of Family Medicine and Pharmacy Practice, Idaho State University and improveRX, LLC; Kjel A. Johnson, Pharm.D, ICORE Healthcare, LLC
92E
Recombinant activated factor VII utilization patterns and thromboembolic Event incidence in critically ill intensive care unit patients
Gretchen M. Brophy, PharmD, VCU Medical College of Virginia; James R. Robles, PhD, VCU Medical College of Virginia
93
Medication adherence and the use of different sources of medicine information
Jurgita Dauksiene, PhD, student, Kaunas Medical University; Raimundas Radziunas, Assoc. Prof., Kaunas Medical University; Jonas Grincevicius, PhD, Kaunas Medical University
94
Who carries meticillin resistant Staphylococcus aureus (MRSA) in the community ?
Sonia Thibaut, PhD, MedQual; Jocelyne Caillon, Pharm, D, PhD, UPRES EA 38 26, Faculté de Médecine; Nathalie Asseray, M.D., Ph.D., UPRES EA 38 26, Faculté de Médecine; Didier Lepelletier, M.D., PhD, UPRES EA 38 26, Faculté de Médecine; Pierre Lombrail, M.D., PhD, MedQual; Gilles Potel, M.D, PhD, UPRES EA 38 26, Faculté de Médecine; Françoise Ballereau, PharmD., Ph.D., MedQual
95
Prophylaxis of venous thromboembolism in orthopaedic surgery: impact of regional guidelines
Francesca Venturini, Pharm., D., M.S., Azienda Ospedaliera di Verona; Andrea Scalvi, M.D., Azienda Ospedaliera di Verona; Valeria Biasi, M. Stat., Azienda Ospedaliera di Verona; Giovanna Scroccaro, Pharm.D., Azienda Ospedaliera di Verona
97
Pharmacokinetics and Dosing of Desirudin in Moderate Renal Impairment Using Monte Carlo Simulation
Joseph S. Bertino Jr., PharmD, Bertino Consulting; Anne N. Nafziger, MD, PhD, Bertino Consulting
98
Salazar-Corcoran equation versus Cockcroft–Gault formula in antimicrobial dosing in obese patients
Teena Abraham, B.S., M.S., Pharm.D., BCPS, New York Methodist Hospital; Steven D. Colby, M.D., New York Methodist Hospital; Natalya Goldshteyn, M.D., New York Methodist Hospital; Larry Bernstein, M.D., New York Methodist Hospital; Nasser Saad, B.S., Pharm.D., New York Methodist Hospital; Lamya Bakoss, B.S., R.Ph., New York Methodist Hospital; Eric Balmir, B.S., R.Ph., M.S., New York Methodist Hospital; Fabienne Vastey, B.S., Pharm.D., New York Methodist Hospital
99E
Influence of plasma exchange on the disposition of the fourth generation cephalosporin cefepime
Rami B. Ibrahim, Pharm.D., Karmanos Cancer Institute and Eugene Applebaum College of Pharmacy and the School of Medicine, Wayne State University; Simon M. Cronin, Pharm.D., Karmanos Cancer Institute and Eugene Applebaum College of Pharmacy, Wayne State University; Chin Liu, Pharm.D., Karmanos Cancer Institute and Eugene Applebaum College of Pharmacy, Wayne State University; Raymond Cha, Pharm.D., Eugene Applebaum College of Pharmacy, Wayne State University; Paul Swerdlow, M.D., Karmanos Cancer Institute and the School of Medicine, Wayne State University; Tomoco Avila, R.N., Karmanos Cancer Institute; Stephen T. Smith, M.S., Karmanos Cancer Institute and Eugene Applebaum College of Pharmacy, Wayne State University; Richard Lewis, M.D., School of Medicine, Wayne State University; David J. Edwards, Pharm.D., Eugene Applebaum College of Pharmacy, Wayne State University
100
Clinical utility of the Child-Pugh score to determine hepatic dose adjustments of selected antimicrobials
Gina M. DeSevo, Pharm.D., Hackensack University Medical Center; Michael A. Wynd, Pharm.D., Hackensack University Medical Center; Arpi G. Kuyumjian, Pharm.D., Hackensack University Medical Center; Cristina E. Cicogna, M.D., Hackensack University Medical Center
Pharmacokinetic study of omeprazole Multi-Unit Pellet System (Losec MUPS®) versus extemporaneous bicarbonate formulation in patients with cerebral palsy and mental retardation
Koen Boussery, Pharm, PhD, Ghent University, Faculty of Pharmaceutical Sciences; Julie De Smet, Pharm, Ghent University, Faculty of Pharmaceutical Sciences; Myriam Van Winckel, MD, PhD, Ghent University Hospital, Paediatric Gastroenterology Dpt; Pieter De Cock, Pharm, Ghent University Hospital, Hospital Pharmacy Dpt.; Peter De Paepe, MD, PhD, Ghent University, Heymans institute of Pharmacology; Jean-Paul Remon, Pharm, PhD, Ghent University, Faculty of Pharmaceutical Sciences; Jan Van Bocxlaer, Pharm, PhD, Ghent University, Faculty of Pharmaceutical Sciences
102
Steady state pharmacokinetics of oral voriconazole and its primary metabolite (UK121-265) pre and post autologous peripheral stem cell transplantation
Jarrett R. Amsden, Pharm.D., Butler University; Scott A. McConnell, PharmD, Cubist Pharmaceuticals; Paul O. Gubbins, Pharm.D., University of Arkansas for Medical Sciences; Elias J. Anaissie, MD, University of Arkansas for Medical Sciences
103
Comparison of the modification of diet in renal disease study equation to the Cockcroft-Gault equation for estimation of vancomycin troughs
Eric Greenberg, Pharm., D., New York Methodist Hospital; Nasser Saad, Pharm. D., New York Methodist Hospital; Teena Abraham, Pharm. D., New York Methodist Hospital; Matt Briggs, Ph. D., New York Methodist Hospital
104
Protamine dosing in cardiopulmonary bypass procedures: is there a best practice?
Eric L. Chernin, BS, Pharmacy, Sarasota Memorial Hospital; David W. Jungst, Pharm.D., Sarasota Memorial Hospital
105
CIMS:Concordance In a Mental health Setting
Debi Bhattacharya, PhD, University of East Anglia; Rebecca Inglis, MPharm, University of East Anglia; Ansuya Solanki, MPharm, University of East Anglia; Savaan Nathwani, MPharm, University of East Anglia; John Hunter, MSc, DipEBP, Norfolk and Waveney Mental Health NHS Foundation Trust
106
Design and validation of a Medication Assessment Tool (MAT) to evaluate the quality of medication use based on international guidelines of asthma management in children aged from 5 to 12 years
Hui-Ping Liu, MSc, Department of Pharmacy, Taipei Medical University-Shuang Ho Hospital; You-Mei Lin, MS, 1. Taipei Medical University, 2. Department of Pharmacy, Taipei Medical University-Shuang Ho Hospital; Steve Hudson, Professor, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde; Julienne Johnson, BPharm, MSc, PhD, MRPharmS, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde; Hsiu-Yu Chien, MS, 1. Taipei Medical University, 2. Department of Pharmacy, Taipei Medical University-Shuang Ho Hospital
107
A prospective assessment of therapeutic efficacy and immune effects of levofloxacin and ofloxacin in multiple-drug resistant tuberculosis
Philip M. Clark, Assist., Prof., Yeditepe University Department of Pharmacy; Sule Apikoglu-Rabus, Ph.D., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department; Bayram Kiran, Assist., Prof., Istanbul University, Istanbul Medical Faculty - Department of Microbiology Virology and Basic Immunology; Turan Karagoz, Associate, Prof., Sureyyapasa Center for Chest Diseases and Thoracic Surgery; Fikret V. Izzettin, Prof., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department
Impact of Uncontrolled Asthma on School Attendance and Social Functioning Among Pediatric Patients
Bonnie Dean, PhD, Cerner LifeSciences; Brian Calimlim, MS, Cerner LifeSciences; Daniel Aguilar, MPH, Cerner LifeSciences; Patricia Sacco, MPH, Novartis Pharmaceuticals Corporation; Robert Maykut, MD, Novartis Pharmaceuticals Corporation; David Tinkelman, MD, National Jewish Medical and Research Center
Demographic and Clinical Factors Associated with Poor Asthma Control in Patients With Severe or Difficult-to-Treat Asthma
Tmirah Haselkorn, PhD, EpiMetrix Inc; James E. Fish, MD, Genentech Inc; Larry Borish, MD, University of Virginia Health Systems; David R. Mink, MD, ICON Clinical Research; Hubert Chen, MD, MPH, University of California - San Francisco; Sally E. Wenzel, MD, University of Pittsburgh
110
An observational study of intentional drug overdoses in a Singapore hospital
Ian Wee, MPharm(ClinPharm), Changi General Hospital; Chai Ling Ong, BSc(Pharm)(Hons), National Heart Centre; Charlene Ong, BSc(Pharm)(Hons), Changi General Hospital
111
Review and revision of the clinical practice of G-CSF treatment in patients undergoing autologous and allogeneic hematopoietic stem cell transplantation at UCSD
Meghana Trivedi, PharmD, PhD, University of California, San Diego; Sue Corringham, RN, University of California, San Diego; Sam Martinez, PharmD, University of California, San Diego; Edward D. Ball, MD, University of California, San Diego; Katherine Medley, PharmD, University of California, San Diego
In vitro dissolution of mycophenolate mofetil: differences observed between innovator and generic formulations
Emmanuel Scheubel, MD, F. Hoffmann-La Roche Ltd; Laurent Adamy, PhD, F. Hoffmann-La Roche Ltd
115
Effect of genetic polymorphism of MRP2 and UGT2B7 on gastrointestinal symptom rating scale in kidney transplant recipients taking mycophenolic acid
Jaewook Yang, Ph.D., Pharm.D, Western University of Health Sciences, College of Pharmacy and National Institute of Transplantation; Puay-hoon Lee, B.S., Singapore General Hospital; Vera Pravica, M.D., Ph.D, USC/National Institute of Transplantation; Ian V. Hutchinson, Ph.D., USC School of Pharmacy; Tariq Shah, M.D., St. Vincent Medical Center and National Institute of Transplantation; David I. Min, Pharm.D., Western University of Health Sciences, College of Pharmacy and National Institute of Transplantation
116
Effect of multiple doses of the cytochrome CYP03A4 inhibitor ketoconazole on the single-dose pharmacokinetics of the highly selective alpha-1A-adrenoceptor antagonist silodosin in healthy men
Lawrence A. Hill, PharmD, Watson Laboratories; Weining Volinn, MS, Watson Laboratories; Gary Hoel, RPh, PhD, Watson Laboratories
117
Maximum tolerated dose of silodosin, a highly selective alpha-1A-adrenoceptor antagonist, for the treatment of symptoms associated with benign prostatic hyperplasia
Lawrence A. Hill, PharmD, Watson Laboratories; Weining Volinn, MS, Watson Laboratories; Gary Hoel, RPh, PhD, Watson Laboratories
118
Effect of renal impairment on plasma concentrations of silodosin and its main metabolites in patients with symptoms of benign prostatic hyperplasia
Leonard S. Marks, MD, University of California Los Angeles; Marc A. Gittelman, MD, South Florida Medical Research; Lawrence A. Hill, PharmD, Watson Laboratories; Weining Volinn, MS, Watson Laboratories; Gary Hoel, RPh, PhD, Watson Laboratories
119
Thorough QTc (TQT) interval assessment of a novel nonimmediate release oral tranexamic acid product on ventricular repolarization in fasting healthy women
Keith A. Moore, PharmD, Xanodyne Pharmaceuticals, Inc; Timothy S. Callahan, PhD, Biomedical Systems, Inc; Pierre Maison-Blanche, MD, Biomedical Systems, Inc; Isabelle Morin, BSc, MDS Pharma Services; Ted Marenco, MSc, MDS Pharma Services
See more of: Original Research